Quantification of decellularized human myocardial matrix: A comparison of six patients

Todd D Johnson1, Ryan C Hill2, Monika Dzieciatkowska2

  • 1Department of Bioengineering, Sanford Consortium for Regenerative Medicine, University of California at San Diego, La Jolla, CA, USA.

Insights

Human cardiac extracellular matrix (ECM) from donor hearts shows significant patient variability. This finding is crucial for developing new allogeneic biomaterials and understanding myocardial composition.

Area of Science:

  • Biochemistry
  • Biomaterials Science
  • Proteomics

Background:

  • The cardiac extracellular matrix (ECM) provides structural and functional support to the myocardium.
  • Understanding human cardiac ECM composition is vital for developing effective biomaterials for cardiac repair.

Purpose of the Study:

  • To characterize and quantitatively analyze human cardiac ECM from six cadaveric donor hearts.
  • To assess patient-to-patient variability in myocardial ECM composition.

Main Methods:

  • Decellularization of human donor hearts to isolate ECM.
  • Quantification of sulfated glycosaminoglycan (sGAG) content and protein analysis via PAGE.
  • Quantitative proteomics using ECM-targeted QconCAT and global LC-MS/MS analysis.

Main Results:

  • Significant patient-to-patient variability observed in sGAG content, PAGE, and QconCAT proteomics.
  • Fibrillar collagens were the predominant proteins in the cardiac ECM.
  • Difficult-to-remove cellular proteins constituted less than 1% of the total protein content.
  • Global proteomics identified over 200 distinct proteins in the human cardiac ECM.

Conclusions:

  • Human myocardial ECM exhibits significant inter-patient variability.
  • This variability has critical implications for the development of allogeneic biomaterials.
  • Findings enhance the understanding of human myocardial ECM composition for future research and applications.
Abstract

Related Concept Videos